Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease

被引:11
|
作者
Muriel, MP [1 ]
Agid, Y [1 ]
Hirsch, E [1 ]
机构
[1] Hop La Pitie Salpetriere, INSERM, U289, F-75013 Paris, France
关键词
basal ganglia; plasticity; dopamine receptor; Parkinson;
D O I
10.1002/mds.1103
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The loss of dopaminergic neurons in the substantia nigra provokes a plasticity of corticostriatal synapses in Parkinson's disease (PD). The corticostriatal pathway nevertheless makes synapses with neurons bearing D1 dopamine receptors (D1R) and/or D2 dopamine receptors. At the ultrastructural level, we analyzed the morphological characteristics of synapses formed by afferent fibers making asymmetric contacts with the dendritic spines of neurons identified by D1R immunoreactivity, in the striatum of control subjects and PD patients. A quantitative analysis of the morphological characteristics of the synapses and of the number of perforated synapses (considered to be very active) was performed. In PD, a 50% increase in the number of perforated synapses making contact with DIR dendritic spines was observed, whereas no change in the number of perforated synapses on non-D1R spines was observed. The change in the number of perforated synapses on DIR dendrites was associated with a slight but nonsignificant increase in the surface area of the corticostriatal afferent fibers and the surface of the mitochondria in these fibers (+29.0% and +34.6%, respectively). This suggests a hyperactivity of corticostriatal fibers in contact with DIR-bearing neurons of the direct pathway in the basal ganglia circuitry. Since stimulation of the direct pathway is thought to alleviate the clinical symptoms of PD, this suggests that the differences observed may be involved in compensatory mechanisms. (C) 2001 Movement Disorder Society.
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [21] Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane
    Dunah, AW
    Standaert, DG
    JOURNAL OF NEUROSCIENCE, 2001, 21 (15) : 5546 - 5558
  • [22] Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease
    Lindgren, Hanna S.
    Ohlin, K. Elisabet
    Cenci, M. Angela
    NEUROPSYCHOPHARMACOLOGY, 2009, 34 (12) : 2477 - 2488
  • [23] Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling
    Deng, Yun-Ping
    Lei, Wan-Long
    Reiner, Anton
    JOURNAL OF CHEMICAL NEUROANATOMY, 2006, 32 (2-4) : 101 - 116
  • [24] Histamine Excites Striatal Dopamine D1 and D2 Receptor-Expressing Neurons via Postsynaptic H1 and H2 Receptors
    Zhuang, Qian-Xing
    Xu, Han-Ting
    Lu, Xu-Juan
    Li, Bin
    Yung, Wing-Ho
    Wang, Jian-Jun
    Zhu, Jing-Ning
    MOLECULAR NEUROBIOLOGY, 2018, 55 (10) : 8059 - 8070
  • [25] Stimulation of dopamine D1 receptors in the avian fronto-striatal system adjusts daily cognitive fluctuations
    Herold, Christina
    Diekamp, Bettina
    Guentuerkuen, Onur
    BEHAVIOURAL BRAIN RESEARCH, 2008, 194 (02) : 223 - 229
  • [26] Differential effects of activating D1 and D2 receptors on electrophysiology of neostriatal neurons in a rat model of Parkinson's disease induced by paraquat and maneb
    Xu, Haiyan
    Chen, Ruirui
    Cai, Xiaoyan
    He, Defu
    NEUROSCIENCE RESEARCH, 2011, 71 (04) : 411 - 420
  • [27] Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients
    Politis, Marios
    Wilson, Heather
    Wu, Kit
    Brooks, David J.
    Piccini, Paola
    NEUROIMAGE-CLINICAL, 2017, 16 : 455 - 460
  • [28] Dopamine D2 Receptors Regulate Collateral Inhibition between Striatal Medium Spiny Neurons
    Lalchandani, Rupa R.
    van der Goes, Marie-Sophie
    Partridge, John G.
    Vicini, Stefano
    JOURNAL OF NEUROSCIENCE, 2013, 33 (35) : 14075 - 14086
  • [29] Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson's Disease
    Bezard, Erwan
    Gray, David
    Kozak, Rouba
    Leoni, Matthew
    Combs, Cari
    Duvvuri, Sridhar
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (04) : 476 - 487
  • [30] Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea
    Bedard, Catherine
    Wallman, Marie-Josee
    Pourcher, Emmanuelle
    Gould, Peter V.
    Parent, Andre
    Parent, Martin
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (08) : 593 - 598